{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:28:25Z","timestamp":1791224905262,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A connection has been established between ocular structural changes and various neurodegenerative diseases. Several studies utilizing optical coherence tomography (OCT) have detected signs of ocular structural alterations among individuals with Huntington's disease (HD). The inconsistent results reported in the literature regarding alterations in the retina and choroid encouraged us to conduct this systematic review and meta-analysis to accumulate the findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic search was carried out in three electronic databases (PubMed, Embase, Scopus) to find studies reporting OCT measurements in HD cases compared with healthy controls (HC). A fixed-effects or random-effects meta-analysis was conducted according to the detected heterogeneity level. Furthermore, subgroup and sensitivity analyses, meta-regression, and quality assessment were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eleven studies were included in the systematic review and 9 studies with a total population of 452 participants (241 cases, and 211 HC) underwent meta-analysis. Results of the analysis denoted that subfoveal choroid had a significantly reduced thickness in HD eyes compared to HC (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Moreover, our analysis indicated that HD cases had a significantly thinner average (<jats:italic>p<\/jats:italic>\u2009=\u20090.0130) and temporal peripapillary retinal nerve fiber layer (pRNFL) (<jats:italic>p<\/jats:italic>\u2009=\u20090.0012) than HC. However, subjects with pre-HD had insignificant differences in average (<jats:italic>p<\/jats:italic>\u2009=\u20090.44) and temporal pRNFL thickness (<jats:italic>p<\/jats:italic>\u2009=\u20090.33) with the HC group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Results of the current systematic review and meta-analysis revealed the significant thinning of average and temporal pRNFL and subfoveal choroid in HD compared to HC. However, OCT currently might be considered insensitive to be applied in the pre-HD population at least until further longitudinal investigations considering variables such as the duration between OCT measurement and disease onset validating OCT as a routine diagnostic tool in HD clinics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-024-12634-4","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T16:02:34Z","timestamp":1724688154000},"page":"6471-6484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optical coherence tomography measurements in Huntington\u2019s disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"271","author":[{"given":"Mahdi","family":"Gouravani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Fekrazad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Mafhoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moein","family":"Ashouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia Cabrera","family":"DeBuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"12634_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282175","author":"P Dusek","year":"2023","unstructured":"Dusek P, Kopal A, Brichova M et al (2023) Is retina affected in Huntington\u2019s disease? Is optical coherence tomography a good biomarker? PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0282175","journal-title":"PLoS ONE"},{"key":"12634_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024240","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC (2017) Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harbor Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a024240","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"12634_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105450","author":"I Mazur-Micha\u0142ek","year":"2022","unstructured":"Mazur-Micha\u0142ek I, Kowalska K, Zielonka D et al (2022) Structural abnormalities of the optic nerve and retina in Huntington\u2019s disease pre-clinical and clinical settings. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23105450","journal-title":"Int J Mol Sci"},{"key":"12634_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/00207454.2018.1489807","volume":"128","author":"E Gatto","year":"2018","unstructured":"Gatto E, Parisi V, Persi G et al (2018) Optical coherence tomography (OCT) study in Argentinean Huntington\u2019s disease patients. Int J Neurosci 128:1157\u20131162. https:\/\/doi.org\/10.1080\/00207454.2018.1489807","journal-title":"Int J Neurosci"},{"key":"12634_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10792-018-0857-7","volume":"39","author":"D Gulmez Sevim","year":"2019","unstructured":"Gulmez Sevim D, Unlu M, Gultekin M, Karaca C (2019) Retinal single-layer analysis with optical coherence tomography shows inner retinal layer thinning in Huntington\u2019s disease as a potential biomarker. Int Ophthalmol 39:611\u2013621. https:\/\/doi.org\/10.1007\/s10792-018-0857-7","journal-title":"Int Ophthalmol"},{"key":"12634_CR47","unstructured":"Ajitkumar A, De Jesus O (2023) Huntington Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 23, 2023"},{"key":"12634_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1468-1331.1994.tb00064.x","volume":"1","author":"T B\u00fcttner","year":"1994","unstructured":"B\u00fcttner T, Schulz S, Kuhn W et al (1994) Impaired colour discrimination in Huntington\u2019s disease. Eur J Neurol 1:153\u2013157. https:\/\/doi.org\/10.1111\/j.1468-1331.1994.tb00064.x","journal-title":"Eur J Neurol"},{"key":"12634_CR7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410340411","volume":"34","author":"W Paulus","year":"1993","unstructured":"Paulus W, Schwarz G, Werner A et al (1993) Impairment of retinal increment thresholds in Huntington\u2019s disease. Ann Neurol 34:574\u2013578. https:\/\/doi.org\/10.1002\/ana.410340411","journal-title":"Ann Neurol"},{"key":"12634_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/s0896-6273(00)80573-5","volume":"21","author":"GR Jackson","year":"1998","unstructured":"Jackson GR, Salecker I, Dong X et al (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21:633\u2013642. https:\/\/doi.org\/10.1016\/s0896-6273(00)80573-5","journal-title":"Neuron"},{"key":"12634_CR9","doi-asserted-by":"publisher","first-page":"A46 LP","DOI":"10.1136\/jnnp-2014-309032.132","volume":"85","author":"S Haider","year":"2014","unstructured":"Haider S, Raftopoulos R, Kapoor R, Tabrizi SJ (2014) E29 macular volume loss in Huntington\u2019s disease on optical coherence tomography\u2014a pilot biomarker study. J Neurol Neurosurg Psychiatry 85:A46 LP-A47 LP. https:\/\/doi.org\/10.1136\/jnnp-2014-309032.132","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12634_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/0013-4694(81)90211-x","volume":"51","author":"G Oepen","year":"1981","unstructured":"Oepen G, Doerr M, Thoden U (1981) Visual (VEP) and somatosensory (SSEP) evoked potentials in Huntington\u2019s chorea. Electroencephalogr Clin Neurophysiol 51:666\u2013670. https:\/\/doi.org\/10.1016\/0013-4694(81)90211-x","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"12634_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1017\/S1355617708080405","volume":"14","author":"BF O\u2019Donnell","year":"2008","unstructured":"O\u2019Donnell BF, Blekher TM, Weaver M et al (2008) Visual perception in prediagnostic and early stage Huntington\u2019s disease. J Int Neuropsychol Soc JINS 14:446\u2013453. https:\/\/doi.org\/10.1017\/S1355617708080405","journal-title":"J Int Neuropsychol Soc JINS"},{"key":"12634_CR12","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00415-015-7869-2","volume":"262","author":"HM Kersten","year":"2015","unstructured":"Kersten HM, Danesh-Meyer HV, Kilfoyle DH, Roxburgh RH (2015) Optical coherence tomography findings in Huntington\u2019s disease: a potential biomarker of disease progression. J Neurol 262:2457\u20132465. https:\/\/doi.org\/10.1007\/s00415-015-7869-2","journal-title":"J Neurol"},{"issue":"10","key":"12634_CR48","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.3390\/jcm11102858","volume":"11","author":"SR Singh","year":"2022","unstructured":"Singh SR, Chhablani J (2022) Optical Coherence Tomography Imaging: Advances in Ophthalmology. J Clin Med 11(10):2858. https:\/\/doi.org\/10.3390\/jcm11102858. Published 18 May 2022","journal-title":"J Clin Med"},{"key":"12634_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12974-023-02763-4","volume":"20","author":"S Mohammadi","year":"2023","unstructured":"Mohammadi S, Gouravani M, Salehi MA et al (2023) Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis. J Neuroinflamm 20:85. https:\/\/doi.org\/10.1186\/s12974-023-02763-4","journal-title":"J Neuroinflamm"},{"key":"12634_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02483-2","author":"MA Salehi","year":"2023","unstructured":"Salehi MA, Rezagholi F, Mohammadi S et al (2023) Optical coherence tomography angiography measurements in Parkinson\u2019s disease: a systematic review and meta-analysis. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-023-02483-2","journal-title":"Eye (Lond)"},{"key":"12634_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12149","volume":"13","author":"OM Rifai","year":"2021","unstructured":"Rifai OM, McGrory S, Robbins CB et al (2021) The application of optical coherence tomography angiography in Alzheimer\u2019s disease: a systematic review. Alzheimer\u2019s Dement (Amst, Neth) 13:e12149. https:\/\/doi.org\/10.1002\/dad2.12149","journal-title":"Alzheimer\u2019s Dement (Amst, Neth)"},{"key":"12634_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"12634_CR17","first-page":"ED000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ et al (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 10:ED000142","journal-title":"Cochrane Database Syst Rev"},{"key":"12634_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2288-14-30","volume":"14","author":"N Takeshima","year":"2014","unstructured":"Takeshima N, Sozu T, Tajika A et al (2014) Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Med Res Methodol 14:30. https:\/\/doi.org\/10.1186\/1471-2288-14-30","journal-title":"BMC Med Res Methodol"},{"key":"12634_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455\u2013463. https:\/\/doi.org\/10.1111\/j.0006-341X.2000.00455.x","journal-title":"Biometrics"},{"key":"12634_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"12634_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.51329\/mehdioptometry103","volume":"1","author":"S Svetozarskiy","year":"2020","unstructured":"Svetozarskiy S, Kopishinskaya S, Smetankin I (2020) Early retinal degeneration in Huntington\u2019s disease based on optical coherence tomography: a case\u2013control study. Med Hypothesis Discov Innov Optom 1:18\u201324. https:\/\/doi.org\/10.51329\/mehdioptometry103","journal-title":"Med Hypothesis Discov Innov Optom"},{"key":"12634_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/mds.26486","volume":"31","author":"C Andrade","year":"2016","unstructured":"Andrade C, Beato J, Monteiro A et al (2016) Spectral-domain optical coherence tomography as a potential biomarker in huntington\u2019s disease. Mov Disord 31:377\u2013383. https:\/\/doi.org\/10.1002\/mds.26486","journal-title":"Mov Disord"},{"key":"12634_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06232-3","author":"E Amini","year":"2022","unstructured":"Amini E, Moghaddasi M, Habibi SAH et al (2022) Huntington\u2019s disease and neurovascular structure of retina. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-022-06232-3","journal-title":"Neurol Sci"},{"key":"12634_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10072-020-04611-2","volume":"42","author":"LG Di Maio","year":"2021","unstructured":"Di Maio LG, Montorio D, Peluso S et al (2021) Optical coherence tomography angiography findings in Huntington\u2019s disease. Neurol Sci 42:995\u20131001. https:\/\/doi.org\/10.1007\/s10072-020-04611-2","journal-title":"Neurol Sci"},{"key":"12634_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11720-3","author":"A Murueta-Goyena","year":"2023","unstructured":"Murueta-Goyena A, Del Pino R, Acera M et al (2023) Retinal thickness as a biomarker of cognitive impairment in manifest Huntington\u2019s disease. J Neurol. https:\/\/doi.org\/10.1007\/s00415-023-11720-3","journal-title":"J Neurol"},{"key":"12634_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2592","author":"RD Schmid","year":"2022","unstructured":"Schmid RD, Remlinger J, Abegg M et al (2022) No optical coherence tomography changes in premanifest Huntington\u2019s disease mutation carriers far from disease onset. Brain Behav. https:\/\/doi.org\/10.1002\/brb3.2592","journal-title":"Brain Behav"},{"key":"12634_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/08164622.2021.1984179","volume":"105","author":"E Christinaki","year":"2022","unstructured":"Christinaki E, Kulenovic H, Hadoux X et al (2022) Retinal imaging biomarkers of neurodegenerative diseases. Clin Exp Optom 105:194\u2013204. https:\/\/doi.org\/10.1080\/08164622.2021.1984179","journal-title":"Clin Exp Optom"},{"key":"12634_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2024.04.007","author":"S Fekrazad","year":"2024","unstructured":"Fekrazad S, Hassanzadeh G, Salehi MA et al (2024) Optical coherence tomography angiography measurements in systemic lupus erythematosus: a systematic review and meta-analysis. Surv Ophthalmol. https:\/\/doi.org\/10.1016\/j.survophthal.2024.04.007","journal-title":"Surv Ophthalmol"},{"key":"12634_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2024.01.002","author":"S Fekrazad","year":"2024","unstructured":"Fekrazad S, Farahani MS, Salehi MA et al (2024) Choroidal thickness in eyes of rheumatoid arthritis patients measured using optical coherence tomography: a systematic review and meta-analysis. Surv Ophthalmol. https:\/\/doi.org\/10.1016\/j.survophthal.2024.01.002","journal-title":"Surv Ophthalmol"},{"key":"12634_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506. https:\/\/doi.org\/10.1016\/s0092-8674(00)81369-0","journal-title":"Cell"},{"key":"12634_CR31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0896-6273(93)90127-d","volume":"11","author":"SH Li","year":"1993","unstructured":"Li SH, Schilling G, Young WS 3rd et al (1993) Huntington\u2019s disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11:985\u2013993. https:\/\/doi.org\/10.1016\/0896-6273(93)90127-d","journal-title":"Neuron"},{"key":"12634_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008025","volume":"4","author":"H Moffitt","year":"2009","unstructured":"Moffitt H, McPhail GD, Woodman B et al (2009) Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 4:e8025. https:\/\/doi.org\/10.1371\/journal.pone.0008025","journal-title":"PLoS ONE"},{"key":"12634_CR33","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/hmg\/11.26.3351","volume":"11","author":"D Helmlinger","year":"2002","unstructured":"Helmlinger D, Yvert G, Picaud S et al (2002) Progressive retinal degeneration and dysfunction in R6 Huntington\u2019s disease mice. Hum Mol Genet 11:3351\u20133359. https:\/\/doi.org\/10.1093\/hmg\/11.26.3351","journal-title":"Hum Mol Genet"},{"key":"12634_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113317","volume":"9","author":"S Ragauskas","year":"2014","unstructured":"Ragauskas S, Leinonen H, Puranen J et al (2014) Early retinal function deficit without prominent morphological changes in the R6\/2 mouse model of Huntington\u2019s disease. PLoS ONE 9:e113317. https:\/\/doi.org\/10.1371\/journal.pone.0113317","journal-title":"PLoS ONE"},{"key":"12634_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/brain\/awn269","volume":"132","author":"F Fortuna","year":"2009","unstructured":"Fortuna F, Barboni P, Liguori R et al (2009) Visual system involvement in patients with Friedreich\u2019s ataxia. Brain J Neurol 132:116\u2013123. https:\/\/doi.org\/10.1093\/brain\/awn269","journal-title":"Brain J Neurol"},{"key":"12634_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981. https:\/\/doi.org\/10.1152\/physrev.00041.2009","journal-title":"Physiol Rev"},{"key":"12634_CR37","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M et al (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20:1438\u20131455. https:\/\/doi.org\/10.1093\/hmg\/ddr024","journal-title":"Hum Mol Genet"},{"key":"12634_CR38","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang C-E et al (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28:2783\u20132792. https:\/\/doi.org\/10.1523\/JNEUROSCI.0106-08.2008","journal-title":"J Neurosci"},{"key":"12634_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-005-1092-7","volume":"110","author":"E Petrasch-Parwez","year":"2005","unstructured":"Petrasch-Parwez E, Saft C, Schlichting A et al (2005) Is the retina affected in Huntington disease? Acta Neuropathol 110:523\u2013525","journal-title":"Acta Neuropathol"},{"key":"12634_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/EB.S9078","volume":"2","author":"MTT Wong-Riley","year":"2010","unstructured":"Wong-Riley MTT (2010) Energy metabolism of the visual system. Eye Brain 2:99\u2013116. https:\/\/doi.org\/10.2147\/EB.S9078","journal-title":"Eye Brain"},{"key":"12634_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177163","volume":"12","author":"E Garcia-Martin","year":"2017","unstructured":"Garcia-Martin E, Pablo LE, Bambo MP et al (2017) Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson\u2019s disease. PLoS ONE 12:e0177163. https:\/\/doi.org\/10.1371\/journal.pone.0177163","journal-title":"PLoS ONE"},{"key":"12634_CR42","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00417-014-2840-y","volume":"252","author":"H Laviers","year":"2014","unstructured":"Laviers H, Zambarakji H (2014) Enhanced depth imaging-OCT of the choroid: a review of the current literature. Graefe\u2019s Arch Clin Exp Ophthalmol 252:1871\u20131883. https:\/\/doi.org\/10.1007\/s00417-014-2840-y","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"12634_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2990.2010.01157.x","volume":"37","author":"J Duran-Vilaregut","year":"2011","unstructured":"Duran-Vilaregut J, del Valle J, Manich G et al (2011) Role of matrix metalloproteinase-9 (MMP-9) in striatal blood\u2013brain barrier disruption in a 3-nitropropionic acid model of Huntington\u2019s disease. Neuropathol Appl Neurobiol 37:525\u2013537. https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01157.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"12634_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G et al (2015) Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology. Ann Neurol 78:160\u2013177. https:\/\/doi.org\/10.1002\/ana.24406","journal-title":"Ann Neurol"},{"key":"12634_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.survophthal.2022.01.007","volume":"68","author":"M Gouravani","year":"2023","unstructured":"Gouravani M, Salehi MA, Mohammadi S, Arevalo JF (2023) Choroidal thickness in eyes of migraine patients measured using spectral domain-optical coherence tomography: a meta-analysis. Surv Ophthalmol 68:67\u201377. https:\/\/doi.org\/10.1016\/j.survophthal.2022.01.007","journal-title":"Surv Ophthalmol"},{"key":"12634_CR46","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1364\/opex.12.002977","volume":"12","author":"SH Yun","year":"2004","unstructured":"Yun SH, Tearney G, de Boer J, Bouma B (2004) Motion artifacts in optical coherence tomography with frequency-domain ranging. Opt Express 12:2977\u20132998. https:\/\/doi.org\/10.1364\/opex.12.002977","journal-title":"Opt Express"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12634-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T03:54:01Z","timestamp":1727927641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12634-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["12634"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12634-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"7 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}